Bodal Chemicals Limited Stock Analysis

Revenue growth maintaining double-digit momentum at 10.4% YoY in Q3 FY26 (Rs. 4895.69 million from operations), demonstrating market demand resilience despite headwinds / Strategic asset monetization generating Rs. 263.50 million in gains from land sales at Unit-II and Unit-III during nine-month period, providing liquidity relief and capital recycling capability / Board-approved land sales at Unit-12 (39.8958 acres) to strategic buyers establishing byproduct consumption units, enabling uninterrupted production and supporting stated top-line and bottom-line growth targets / Manageable tax burden with effective tax rate of only 2.98%, improving cash retention and reducing the tax drag on profitability

Turkish subsidiaries operating in hyperinflationary economy created Rs. 43.37 million loss for nine months under Ind AS 29, representing 1,837% of actual profit after tax and indicating severe currency and economic headwinds that are likely to persist / Profitability deteriorated to near-distress levels with net profit margin of 0.05% and minimal EPS of Rs. 0.02, making the company essentially unprofitable on operational metrics and vulnerable to further shocks / Finance costs of Rs. 194.41 million in Q3 alone coupled with minimal pre-tax profits of Rs. 2.35 million indicate excessive leverage and weak debt servicing capacity, with interest burden consuming most operational earnings / Inventory buildup evidenced by negative change in inventory of Rs. 29.78 million signals potential demand softness, excess working capital strain, or operational challenges that could require future write-downs / Heavy dependence on non-core asset sales (land monetization) to achieve financial targets indicates underlying operational profitability is insufficient to support growth plans, raising sustainability concerns / New Labour Code implementation increasing gratuity liability by Rs. 17.97 million and redefining wage calculations creates structural cost inflation that will persistently pressure margins going forward

Revenue from operations increased 10.4% YoY in Q3 FY26 to Rs. 4,895.69 million, showing demand resilience despite operating headwinds. / The company generated Rs. 150.88 million of other income in Q3 FY26, which helped offset pressure on operating profitability. / Non-core asset monetization is progressing, with Rs. 263.50 million realized from sale of portions of Unit-II and Unit-III during the nine-month period. / Board-approved sale of 39.8958 acres at Unit-12 (15.1875 + 24.7083 acres) is tied to byproduct offtake (chlorine/hydrogen), supporting continuity of production. / The limited review opinion is unqualified, reducing near-term accounting credibility concerns around reported numbers.

Earnings quality is weak: Q3 PAT was only Rs. 2.42 million on total revenue of Rs. 5,046.57 million, with net profit margin at just 0.05%. / Finance costs remain high at Rs. 194.41 million in Q3, materially constraining pre-tax profitability (PBT only Rs. 2.35 million). / Turkish hyperinflation exposure continues to erode earnings, with Ind AS 29 impact of Rs. 10.03 million in Q3 and Rs. 43.37 million in 9M FY26. / Cost inflation from regulation is visible: employee cost reached Rs. 341.26 million in Q3, including Rs. 17.97 million labour-code-related gratuity impact. / Working-capital pressure is indicated by negative change in inventories of Rs. 29.78 million (inventory buildup), while operating cash flow/FCF/debt metrics are not provided in the extracted data, limiting balance-sheet and liquidity visibility.

Revenue growth of 10.4% year-over-year in Q3 FY26 with operations revenue reaching Rs. 4895.69 million demonstrates top-line expansion capability / Successful asset monetization generated Rs. 263.50 million from non-core land sales at Unit-II and Unit-III Vatva during the nine-month period / Board approved additional land sales totaling 39.8958 acres at Unit-12 to strategic buyers who will consume chlorine and hydrogen byproducts, enabling uninterrupted production / Strong other income of Rs. 150.88 million in Q3 provides revenue diversification beyond core operations

Profitability crisis with PAT of only Rs. 2.42 million and net margin of 0.05% despite Rs. 4895.69 million in operational revenue, indicating severe margin compression / Turkish subsidiary hyperinflation losses of Rs. 43.37 million for nine months (Rs. 10.03 million in Q3 alone) creating persistent structural drag on consolidated earnings / Rising employee costs of Rs. 341.26 million in Q3 with Rs. 17.97 million additional gratuity liability from new Labour Code implementation increasing fixed cost burden / Elevated finance costs of Rs. 194.41 million in Q3 indicate high debt servicing burden that consumes operating profits / Negative inventory change of Rs. 29.78 million suggests inventory buildup and potential working capital stress or demand slowdown / Exceptionally low tax rate of 2.98% signals minimal taxable income and reflects the weak underlying profitability of operations

Revenue growth momentum with 9M FY26 consolidated revenue at Rs. 14,242 million versus Rs. 12,976 million in 9M FY25, representing 9.8% YoY growth / Strong asset monetization with Rs. 263.50 million profit from sale of non-core industrial units (Unit-II and Unit-III) during 9M FY26 / Strategic byproduct management through planned sale of 39.9 acres of land to buyers who will set up units consuming chlorine and hydrogen byproducts, enabling uninterrupted production / Improved inventory management with negative change in inventories of Rs. 29.78 million in Q3 FY26 versus positive Rs. 266.58 million in Q2 FY26, indicating better stock turnover / Reduced finance costs on sequential basis at Rs. 194.41 million in Q3 FY26 versus Rs. 199.15 million in Q2 FY26, showing marginally better debt servicing efficiency

Sharp profit decline in Q3 FY26 with consolidated PAT of Rs. 2.42 million versus Rs. 54.15 million in Q3 FY25, representing 95.5% YoY deterioration / Hyperinflation accounting impact from Turkish subsidiaries with Rs. 43.37 million loss for 9M FY26 and Rs. 10.03 million in Q3 FY26, creating earnings volatility / Material one-time employee cost burden of Rs. 17.97 million due to new labor codes redefining wages, permanently increasing the cost base / High other expenses at Rs. 4,422.71 million for 9M FY26 (31% of revenue), indicating cost management challenges despite revenue growth / Dependence on asset sales for profitability with Rs. 178.94 million gain in Q2 FY26 and Rs. 84.56 million in Q3 FY26, masking weak core operating performance / Foreign exchange translation losses of Rs. 22.64 million in 9M FY26 from foreign subsidiaries, adding to earnings pressure

Consolidated revenue from operations increased 10.4% YoY in Q3 (Rs. 4,895.69 million vs Rs. 4,434.66 million) and about 9.8% in 9M (Rs. 14,242.24 million vs Rs. 12,975.55 million). / 9M consolidated PAT rose to Rs. 157.68 million from Rs. 39.98 million, with EPS improving to Rs. 1.25 from Rs. 0.32. / Non-core asset monetization was executed, with Rs. 263.50 million profit on sale recorded in 9M FY26 under Other Income. / Board approved further land rationalization (15.1875 acres and 24.7083 acres at Unit-12) tied to byproduct offtake (chlorine and hydrogen), indicating strategic integration intent. / Limited review reports are unmodified on both standalone and consolidated results, with auditors not flagging material misstatement.

Quarterly earnings deteriorated sharply: consolidated PAT fell to Rs. 2.42 million in Q3 FY26 from Rs. 59.93 million in Q2 and Rs. 54.15 million in Q3 FY25. / Q3 profitability was extremely thin, with PBT of Rs. 2.35 million on total income of Rs. 5,046.57 million (near break-even margin). / Finance cost remains high at Rs. 194.41 million in Q3 and Rs. 609.88 million in 9M, constraining net profitability. / Earnings are influenced by non-recurring/non-operating items, including Rs. 263.50 million asset-sale gains within 9M Other Income of Rs. 390.63 million. / International exposure adds volatility: hyperinflation accounting loss from Turkey subsidiaries was Rs. 10.03 million in Q3 and Rs. 43.37 million in 9M, while 9M OCI included negative translation impact of Rs. 22.64 million.